Viferon, 40000me/g ointment, 12g

Composition

1 g of ointment for external and topical use contains the Active ingredient:

human recombinant Interferon alfa-2 40,000 IU;

excipients:

tocopherol acetate 0.02 g,

lanolin anhydrous 0.34 g,

medical vaseline 0.45 g,

peach oil 0.12 g,

purified water up to 1.0 g

Pharmacological action

An immunomodulatory and antiviral drug. Human recombinant Interferon alfa-2 has pronounced antiviral, antiproliferative and immunomodulatory properties.

In the presence of excipients included in the preparation (the antioxidant tocopherol acetate), the specific antiviral activity of human recombinant interferon alpha – 2 increases, and its immunomodulatory effect increases (stimulation of the phagocytic function of neutrophils in the lesions).

When applied externally and topically, systemic absorption of interferon is low.

Indications

For the treatment of herpetic infections (Herpes simplex 1 and 2 types) of the skin and mucous membranes of various localization.

As part of the complex therapy of influenza and other acute respiratory viral infections in children aged from 1 year.

Use during pregnancy and lactation

Since the systemic absorption of interferon is low with external and topical application and the drug has an effect only in the lesion, it is possible to use the drug VIFERON, ointment during pregnancy and lactation.

Contraindications

Individual intolerance to the components of the drug.

Children under 1 year of age.

Side effects

In most cases, the drug VIFERON, ointment for external and topical use is well tolerated. When applied to the nasal mucosa, side effects (rhinorrhea, sneezing, burning of the nasal mucosa) are mild and transient and disappear independently after discontinuation of the drug.

Interaction

The preparation VIFERON, an ointment for external and topical use, is compatible and well combined with all medications used in the treatment of acute respiratory viral infections, including influenza, viral (herpetic) lesions of the skin and mucous membranes.

How to take, course of use and dosage

Viferon ointment is applied in a thin layer on the lesions 3-4 times a day, the duration of treatment is 5-7 days.

It is recommended to start treatment immediately when the first signs of skin and mucous membrane lesions (itching, burning, redness) appear.

When treating recurrent herpes, it is advisable to start treatment in the prodromal period or at the very beginning of the appearance of signs of relapse.

For the treatment of influenza and other acute respiratory infections, the ointment is applied in a thin layer to the nasal mucosa 3-4 times a day:

• children from 1 year to 2 years of 2500 IU (1 pea with a diameter of 0.5 cm),3 times a day
• children 2 to 12 years of 2500 IU (1 pea with a diameter of 0.5 cm) 4 times a day,
• children from 12 to 18 years 5000 IU (1 pea with a diameter of 1 cm) 4 times a day.

The duration of treatment is 5 days.

Form of production

Ointment for external use.

Storage conditions

At a temperature of 2-8 °C.

Keep out of reach of children.

Shelf life

1 year

Active ingredient

Interferon alfa-2b

Dosage form

ointment

Description

Pregnant women as prescribed by a doctor, Nursing mothers as prescribed by a doctor, Children over 1 year of age

Indications

Flu, Herpes